Replies to post #42316 on Ocata Therapeutics Inc fka OCAT

[rocky301]

Something tells me these last bondholder cases spells more
dilution

ACT has already said just that in recent 10K..
411MM already issued in settlement and looking at approx 135MM more..


Finance costs increased by $56,501,893 primarily due to the warrant and debenture settlements that occurred during the year. We have issued approximately 126.2 million shares related to settlements during 2011 and issued approximately 285.5 million shares on January 31, 2012 and February 7, 2012 which were accrued for as finance costs during the year ended December 31, 2011. We anticipate having to issue approximately an additional 135.5 million shares related to debenture settlements that were accrued for as finance costs at December 31, 2011.